155 related articles for article (PubMed ID: 11208636)
21. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P
Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I).
Kerwin EM; D'Urzo AD; Gelb AF; Lakkis H; Garcia Gil E; Caracta CF;
COPD; 2012 Apr; 9(2):90-101. PubMed ID: 22320148
[TBL] [Abstract][Full Text] [Related]
23. Rehabilitation of patients with chronic obstructive pulmonary disease. Exercise twice a week is not sufficient!
Ringbaek TJ; Broendum E; Hemmingsen L; Lybeck K; Nielsen D; Andersen C; Lange P
Respir Med; 2000 Feb; 94(2):150-4. PubMed ID: 10714421
[TBL] [Abstract][Full Text] [Related]
24. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C
Am J Respir Crit Care Med; 2002 Nov; 166(10):1358-63. PubMed ID: 12406823
[TBL] [Abstract][Full Text] [Related]
25. Changes in dyspnea, health status, and lung function in chronic airway disease.
Mahler DA; Tomlinson D; Olmstead EM; Tosteson AN; O'Connor GT
Am J Respir Crit Care Med; 1995 Jan; 151(1):61-5. PubMed ID: 7812573
[TBL] [Abstract][Full Text] [Related]
26. Validation of the St. George's Respiratory Questionnaire in bronchiectasis.
Wilson CB; Jones PW; O'Leary CJ; Cole PJ; Wilson R
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):536-41. PubMed ID: 9279236
[TBL] [Abstract][Full Text] [Related]
27. One-year change in health status and subsequent outcomes in COPD.
Wilke S; Jones PW; Müllerova H; Vestbo J; Tal-Singer R; Franssen FM; Agusti A; Bakke P; Calverley PM; Coxson HO; Crim C; Edwards LD; Lomas DA; MacNee W; Rennard SI; Yates JC; Wouters EF; Spruit MA
Thorax; 2015 May; 70(5):420-5. PubMed ID: 25782757
[TBL] [Abstract][Full Text] [Related]
28. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease.
Osman IM; Godden DJ; Friend JA; Legge JS; Douglas JG
Thorax; 1997 Jan; 52(1):67-71. PubMed ID: 9039248
[TBL] [Abstract][Full Text] [Related]
29. The determinants of poor respiratory health status in adults living with human immunodeficiency virus infection.
Leung JM; Liu JC; Mtambo A; Ngan D; Nashta N; Guillemi S; Harris M; Lima VD; Mattman A; Shaipanich T; Raju R; Hague C; Leipsic JA; Sin DD; Montaner JS; Man SF
AIDS Patient Care STDS; 2014 May; 28(5):240-7. PubMed ID: 24742270
[TBL] [Abstract][Full Text] [Related]
30. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
Vestbo J; Prescott E; Lange P
Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
[TBL] [Abstract][Full Text] [Related]
31. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia.
Okubadejo AA; Jones PW; Wedzicha JA
Thorax; 1996 Jan; 51(1):44-7. PubMed ID: 8658368
[TBL] [Abstract][Full Text] [Related]
32. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease.
Gallefoss F; Bakke PS; Rsgaard PK
Am J Respir Crit Care Med; 1999 Mar; 159(3):812-7. PubMed ID: 10051255
[TBL] [Abstract][Full Text] [Related]
33. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
Jones PW; Quirk FH; Baveystock CM; Littlejohns P
Am Rev Respir Dis; 1992 Jun; 145(6):1321-7. PubMed ID: 1595997
[TBL] [Abstract][Full Text] [Related]
34. Small, moderate, and large changes, and the minimum clinically important difference in the University of California, San Diego Shortness of Breath Questionnaire.
Horita N; Miyazawa N; Morita S; Kojima R; Kimura N; Kaneko T; Ishigatsubo Y
COPD; 2014 Feb; 11(1):26-32. PubMed ID: 23886071
[TBL] [Abstract][Full Text] [Related]
35. Differences in Health-Related Quality of Life Between New Mexican Hispanic and Non-Hispanic White Smokers.
Diaz AA; Petersen H; Meek P; Sood A; Celli B; Tesfaigzi Y
Chest; 2016 Oct; 150(4):869-876. PubMed ID: 27321735
[TBL] [Abstract][Full Text] [Related]
36. Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. Quality of Life in COPD Study Group.
Alonso J; Prieto L; Ferrer M; Vilagut G; Broquetas JM; Roca J; Batlle JS; Antó JM
J Clin Epidemiol; 1998 Nov; 51(11):1087-94. PubMed ID: 9817126
[TBL] [Abstract][Full Text] [Related]
37. The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second.
Tashkin DP; Detels R; Simmons M; Liu H; Coulson AH; Sayre J; Rokaw S
Am J Respir Crit Care Med; 1994 May; 149(5):1209-17. PubMed ID: 8173761
[TBL] [Abstract][Full Text] [Related]
38. Salmeterol combined with fluticasone propionate improved COPD in patients during stable stage.
Lu D; Ma J; Yang X
Int J Clin Exp Med; 2014; 7(9):2907-11. PubMed ID: 25356157
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease.
Krzyzanowski M; Jedrychowski W; Wysocki M
Am Rev Respir Dis; 1986 Nov; 134(5):1011-9. PubMed ID: 3777663
[TBL] [Abstract][Full Text] [Related]
40. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease.
Saudny-Unterberger H; Martin JG; Gray-Donald K
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):794-9. PubMed ID: 9309995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
